These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11232014)

  • 1. Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: histomorphometric evidence in a longitudinal study.
    Khastgir G; Studd J; Holland N; Alaghband-Zadeh J; Fox S; Chow J
    J Clin Endocrinol Metab; 2001 Jan; 86(1):289-95. PubMed ID: 11232014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anabolic effect of long-term estrogen replacement on bone collagen in elderly postmenopausal women with osteoporosis.
    Khastgir G; Studd J; Holland N; Alaghband-Zadeh J; Sims TJ; Bailey AJ
    Osteoporos Int; 2001; 12(6):465-70. PubMed ID: 11446562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early estrogen replacement therapy reverses the rapid loss of trabecular bone volume and prevents further deterioration of connectivity in the rat.
    Lane NE; Haupt D; Kimmel DB; Modin G; Kinney JH
    J Bone Miner Res; 1999 Feb; 14(2):206-14. PubMed ID: 9933474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in collagen composition and cross-links in bone and skin of osteoporotic postmenopausal women treated with percutaneous estradiol implants.
    Holland EF; Studd JW; Mansell JP; Leather AT; Bailey AJ
    Obstet Gynecol; 1994 Feb; 83(2):180-3. PubMed ID: 8290178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study of the effect of subcutaneous estrogen replacement on bone in young women with Turner's syndrome.
    Khastgir G; Studd JW; Fox SW; Jones J; Alaghband-Zadeh J; Chow JW
    J Bone Miner Res; 2003 May; 18(5):925-32. PubMed ID: 12733734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of postmenopausal osteoporosis with transdermal estrogen.
    Lufkin EG; Wahner HW; O'Fallon WM; Hodgson SF; Kotowicz MA; Lane AW; Judd HL; Caplan RH; Riggs BL
    Ann Intern Med; 1992 Jul; 117(1):1-9. PubMed ID: 1534476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group.
    Bone HG; Greenspan SL; McKeever C; Bell N; Davidson M; Downs RW; Emkey R; Meunier PJ; Miller SS; Mulloy AL; Recker RR; Weiss SR; Heyden N; Musliner T; Suryawanshi S; Yates AJ; Lombardi A
    J Clin Endocrinol Metab; 2000 Feb; 85(2):720-6. PubMed ID: 10690882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
    Christiansen C; Riis BJ
    J Clin Endocrinol Metab; 1990 Oct; 71(4):836-41. PubMed ID: 2205624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histomorphometric changes in the skeleton of postmenopausal women with low bone mineral density treated with percutaneous estradiol implants.
    Holland EF; Chow JW; Studd JW; Leather AT; Chambers TJ
    Obstet Gynecol; 1994 Mar; 83(3):387-91. PubMed ID: 8127530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-progestogen replacement therapy in postmenopausal women--is 1 mg estradiolvalerate sufficient to maintain axial trabecular bone density?
    Dören M; Schneider HP
    Int J Clin Pharmacol Ther; 1994 May; 32(5):254-8. PubMed ID: 7921520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
    Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
    J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone histology in postmenopausal osteoporosis--variations in cellular activity].
    Lozo P; Krpan D; Krvavica A; Vukelić Baturić T; Fistonić I; Kusec V
    Acta Med Croatica; 2004; 58(1):5-11. PubMed ID: 15125387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial.
    Arrenbrecht S; Boermans AJ
    Osteoporos Int; 2002; 13(2):176-83. PubMed ID: 11908492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy increases trabecular and cortical bone density in osteoporotic women.
    Bagur A; Wittich A; Ghiringhelli G; Vega E; Mautalen C
    Medicina (B Aires); 1996; 56(3):247-51. PubMed ID: 9035480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: a randomized controlled trial.
    Reid IR; Cundy T; Grey AB; Horne A; Clearwater J; Ames R; Orr-Walker BJ; Wu F; Evans MC; Gamble GD; King A
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2446-52. PubMed ID: 17440020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous estrogen in prevention of early postmenopausal bone loss in Chinese women.
    Sun A; Lin S; Yu W; Qin M; Chen F; Zhang Y; Wei Y; de Lignieres B
    Chin Med J (Engl); 2002 Dec; 115(12):1790-5. PubMed ID: 12622925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
    Lane NE; Sanchez S; Genant HK; Jenkins DK; Arnaud CD
    Osteoporos Int; 2000; 11(5):434-42. PubMed ID: 10912846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
    Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
    N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal therapy with estradiol and testosterone implants: bone protection?
    Britto R; Araújo L; Barbosa I; Silva L; Rocha S; Valente AP
    Gynecol Endocrinol; 2011 Feb; 27(2):96-100. PubMed ID: 20504104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.